<?xml version="1.0" encoding="UTF-8"?>
<p>Development of biological standards and assays is important for evaluating vaccine-elicited immune responses and promoting standardization, transparency, and comparability among the vaccine candidates. There are currently no available international antibody standards for Lassa, MERS-CoV, or Nipah, and there is aÂ wide variety of intermediate standards currently used by Lassa vaccine developers.</p>
